HER-2/neu amplification testing in breast cancer by Multiplex Ligation-dependent Probe Amplification: influence of manual- and laser microdissection.

Abstract:

BACKGROUND:Accurate assessment of HER-2/neu status is crucial for proper prognostic information and to offer direct appropriate treatment for breast cancer patients. Next to immunohistochemistry (IHC) to evaluate HER2 protein overexpression, a second line gene amplification test is generally deemed necessary for cases with equivocal protein expression. Recently, a new PCR based test, called Multiplex Ligation-dependent Probe Amplification (MLPA), was introduced as a simple and quick method to assess HER-2/neu gene amplification status in invasive breast cancer. MLPA was previously shown to correlate well with IHC and in situ hybridization (ISH), but a low tumor percentage in the tissue tested could negatively affect the accuracy of MLPA results. METHODS:To examine this, MLPA was repeated in 42 patients after serial H&E section guided manual dissection with a scalpel and after laser microdissection of the tumor. RESULTS:Both dissection techniques led to higher HER2 gene copy number ratios and thereby made MLPA more quantitative. Concordance between MLPA and ISH improved from 61% to 84% after manual microdissection and to 90% after laser microdissection. CONCLUSION:Manual and laser microdissection similarly increase the dynamic range of MLPA copy number ratios which is a technical advantage. As clinically a dichotomization between normal and amplified suffices and MLPA is relatively unsensitive to tumor content, microdissection before MLPA may not be routinely necessary but may be advisable in case of very low tumor content (

journal_name

BMC Cancer

journal_title

BMC cancer

authors

Moelans CB,de Weger RA,Ezendam C,van Diest PJ

doi

10.1186/1471-2407-9-4

subject

Has Abstract

pub_date

2009-01-05 00:00:00

pages

4

issn

1471-2407

pii

1471-2407-9-4

journal_volume

9

pub_type

杂志文章
  • Metformin and longevity (METAL): a window of opportunity study investigating the biological effects of metformin in localised prostate cancer.

    abstract:BACKGROUND:Metformin is a biguanide oral hypoglycaemic agent commonly used for the treatment of type 2 diabetes mellitus. In addition to its anti-diabetic effect, metformin has also been associated with a reduced risk of cancer incidence of a number of solid tumours, including prostate cancer (PCa). However, the underl...

    journal_title:BMC cancer

    pub_type: 杂志文章,随机对照试验

    doi:10.1186/s12885-017-3458-3

    authors: Crawley D,Chandra A,Loda M,Gillett C,Cathcart P,Challacombe B,Cook G,Cahill D,Santa Olalla A,Cahill F,George G,Rudman S,Van Hemelrijck M

    更新日期:2017-07-21 00:00:00

  • The T790M resistance mutation in EGFR is only found in cfDNA from erlotinib-treated NSCLC patients that harbored an activating EGFR mutation before treatment.

    abstract:BACKGROUND:Lung cancer patients with an activating mutation in the EGFR (epidermal growth factor receptor) can develop resistance to erlotinib treatment, which is often mediated by the T790M resistance mutation in EGFR. The difficulties in obtaining biopsies at progression make it challenging to investigate the appeara...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4108-0

    authors: Demuth C,Madsen AT,Weber B,Wu L,Meldgaard P,Sorensen BS

    更新日期:2018-02-15 00:00:00

  • Investigating young women's motivations to engage in early mammography screening in Switzerland: results of a cross-sectional study.

    abstract:BACKGROUND:The scientific and public debate concerning organized mammography screening is unprecedentedly strong. With research evidence concerning its efficacy being ambiguous, the recommendations pertaining to the age-thresholds for program inclusion vary between - and even within - countries. Data shows that young w...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3180-1

    authors: Labrie NH,Ludolph R,Schulz PJ

    更新日期:2017-03-21 00:00:00

  • Ovarian cancer risk and common variation in the sex hormone-binding globulin gene: a population-based case-control study.

    abstract:BACKGROUND:The sex hormone-binding globulin (SHBG) is a carrier protein that modulates the bio-availability of serum sex steroid hormones, which may be involved in ovarian cancer. We evaluated whether common genetic variation in SHBG and its 3' neighbor ATP1B2, in linkage disequilibrium, is associated with the risk of ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-7-60

    authors: Garcia-Closas M,Brinton LA,Lissowska J,Richesson D,Sherman ME,Szeszenia-Dabrowska N,Peplonska B,Welch R,Yeager M,Zatonski W,Chanock SJ

    更新日期:2007-04-05 00:00:00

  • Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysis.

    abstract:BACKGROUND:Febrile neutropenia (FN) occurs following myelosuppressive chemotherapy and is associated with morbidity, mortality, costs, and chemotherapy reductions and delays. Granulocyte colony-stimulating factors (G-CSFs) stimulate neutrophil production and may reduce FN incidence when given prophylactically following...

    journal_title:BMC cancer

    pub_type: 杂志文章,meta分析,评审

    doi:10.1186/1471-2407-11-404

    authors: Cooper KL,Madan J,Whyte S,Stevenson MD,Akehurst RL

    更新日期:2011-09-23 00:00:00

  • Acrokeratosis paraneoplastica in serous ovarian carcinoma: case report.

    abstract:BACKGROUND:Acrokeratosis paraneoplastica is a rare paraneoplastic phenomenon associated with upper aerodigestive tract carcinomas, usually manifesting as psoriasiform keratosis over the acral sites. It is primarily seen in white males above the age of 40 years. Here we report a case of paraneoplastic acrokeratosis in a...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-1527-z

    authors: Hempen A,Samartzis EP,Kamarachev J,Fink D,Dedes KJ

    更新日期:2015-07-08 00:00:00

  • Genetic associations between the miRNA polymorphisms miR-130b (rs373001), miR-200b (rs7549819), and miR-495 (rs2281611) and colorectal cancer susceptibility.

    abstract:BACKGROUND:Recent studies have extensively investigated the role of miRNAs in colorectal cancer (CRC), and several associations have been reported. In addition, single nucleotide polymorphisms (SNPs) in promoter regions of miRNAs have been shown to affect miRNA expression. Therefore, we aimed to analyze the effect of m...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-5641-1

    authors: Kim EG,Kim JO,Park HS,Ryu CS,Oh J,Jun HH,Kim JW,Kim NK

    更新日期:2019-05-22 00:00:00

  • Angiopoietin-1 deficiency increases tumor metastasis in mice.

    abstract:BACKGROUND:Angipoietin-1 activation of the tyrosine kinase receptor Tek expressed mainly on endothelial cells leads to survival and stabilization of endothelial cells. Studies have shown that Angiopoietin-1 counteracts permeability induced by a number of stimuli. Here, we test the hypothesis that loss of Angiopoietin-1...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3531-y

    authors: Michael IP,Orebrand M,Lima M,Pereira B,Volpert O,Quaggin SE,Jeansson M

    更新日期:2017-08-11 00:00:00

  • Successfully treatment by eribulin in visceral crisis: a case of lymphangitic carcinomatosis from metastatic breast cancer.

    abstract:BACKGROUND:Metastatic breast cancer (MBC) rest an incurably disease associated with bad prognosis and a median overall survival of 23-31 months. There are several treatment options including chemotherapy and sometimes endocrine therapy. Currently, there is no standard treatment for patients with MBC who have already be...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4725-7

    authors: Fumet JD,Wickre M,Jacquot JP,Bizollon MH,Melis A,Vanoli A,Viel E

    更新日期:2018-08-20 00:00:00

  • Assessment of laparoscopic stomach preserving surgery with sentinel basin dissection versus standard gastrectomy with lymphadenectomy in early gastric cancer-A multicenter randomized phase III clinical trial (SENORITA trial) protocol.

    abstract:BACKGROUND:Along with the marked increase in early gastric cancer (EGC) in the Eastern countries, there has been an effort to adopt the sentinel node concept in EGC to preserve gastric function and reduce the occurrence of postoperative complications. Based on promising results from a previous quality control study, th...

    journal_title:BMC cancer

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1186/s12885-016-2336-8

    authors: Park JY,Kim YW,Ryu KW,Nam BH,Lee YJ,Jeong SH,Park JH,Hur H,Han SU,Min JS,An JY,Hyung WJ,Cho GS,Jeong GA,Jeong O,Park YK,Jung MR,Yoon HM,Eom BW

    更新日期:2016-05-31 00:00:00

  • Suppression of local invasion of ameloblastoma by inhibition of matrix metalloproteinase-2 in vitro.

    abstract:BACKGROUND:Ameloblastomas are odontogenic neoplasms characterized by local invasiveness. This study was conducted to address the role of matrix metalloproteinase-2 (MMP-2) in the invasiveness of ameloblastomas. METHODS:Plasmids containing either MMP-2 siRNA or tissue inhibitor of metalloproteinase-2 (TIMP-2) cDNA were...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-8-182

    authors: Wang A,Zhang B,Huang H,Zhang L,Zeng D,Tao Q,Wang J,Pan C

    更新日期:2008-06-30 00:00:00

  • Clinicopathological features of breast cancer patients with internal mammary and/or supraclavicular lymph node recurrence without distant metastasis.

    abstract:BACKGROUND:Internal mammary and/or supraclavicular (IM-SC) lymph node (LN) recurrence without distant metastasis (DM) in patients with breast cancer is rare, and there have been few reports on its clinical outcomes. METHODS:We enrolled 4237 patients with clinical stage I-IIIC breast cancer treated between January 2007...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07442-8

    authors: Inari H,Teruya N,Kishi M,Horii R,Akiyama F,Takahashi S,Ito Y,Ueno T,Iwase T,Ohno S

    更新日期:2020-09-29 00:00:00

  • Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients.

    abstract:BACKGROUND:Circulating tumour DNA (ctDNA) may serve as a measure of tumour burden and a useful tool for non-invasive monitoring of cancer. However, ctDNA is not always detectable in patients at time of diagnosis of metastatic disease. Therefore, there is a need to understand the correlation between ctDNA levels and the...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4637-6

    authors: McEvoy AC,Warburton L,Al-Ogaili Z,Celliers L,Calapre L,Pereira MR,Khattak MA,Meniawy TM,Millward M,Ziman M,Gray ES

    更新日期:2018-07-09 00:00:00

  • Effects on quality of life, anti-cancer responses, breast conserving surgery and survival with neoadjuvant docetaxel: a randomised study of sequential weekly versus three-weekly docetaxel following neoadjuvant doxorubicin and cyclophosphamide in women wit

    abstract:BACKGROUND:Weekly docetaxel has occasionally been used in the neoadjuvant to downstage breast cancer to reduce toxicity and possibly enhance quality of life. However, no studies have compared the standard three weekly regimen to the weekly regimen in terms of quality of life. The primary aim of our study was to compare...

    journal_title:BMC cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1186/1471-2407-11-179

    authors: Walker LG,Eremin JM,Aloysius MM,Vassanasiri W,Walker MB,El-Sheemy M,Cowley G,Beer J,Samphao S,Wiseman J,Jibril JA,Valerio D,Clarke DJ,Kamal M,Thorpe GW,Baria K,Eremin O

    更新日期:2011-05-18 00:00:00

  • A non-randomised, single-centre comparison of induction chemotherapy followed by radiochemotherapy versus concomitant chemotherapy with hyperfractionated radiotherapy in inoperable head and neck carcinomas.

    abstract:BACKGROUND:The application of induction chemotherapy failed to provide a consistent benefit for local control in primary treatment of advanced head and neck (H&N) cancers. The aim of this study was to compare the results of concomitant application of radiochemotherapy for treating locally advanced head-and-neck carcino...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-6-30

    authors: Graf R,Hildebrandt B,Tilly W,Riess H,Felix R,Budach V,Wust P

    更新日期:2006-02-01 00:00:00

  • Might radiation therapy in addition to chemotherapy improve overall survival of patients with non-oligometastatic Stage IV non-small cell lung cancer?: Secondary analysis of two prospective studies.

    abstract:BACKGROUND:The role of radiation therapy in addition to chemotherapy has not been well established in non-oligometastatic Stage IV non-small cell lung cancer (NSCLC). We aimed to investigate overall survival (OS) of non-oligometastatic Stage IV NSCLC treated with chemotherapy with concurrent radiation to the primary tu...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2952-3

    authors: Su S,Hu Y,Ouyang W,Ma Z,Li Q,Li H,Wang Y,Wang X,Li T,Li J,Chen M,Lu Y,Bai Y,He Z,Lu B

    更新日期:2016-11-21 00:00:00

  • Down-regulation of SFRP1 as a putative tumor suppressor gene can contribute to human hepatocellular carcinoma.

    abstract:BACKGROUND:Hepatocellular carcinoma (HCC) is one of the most common cancers in the world. SFRP1 (the secreted frizzled-related protein 1), a putative tumor suppressor gene mapped onto chromosome 8p12-p11.1, the frequent loss of heterozygosity (LOH) region in human HCC, encodes a Wingless-type (Wnt) signaling antagonist...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-7-126

    authors: Huang J,Zhang YL,Teng XM,Lin Y,Zheng DL,Yang PY,Han ZG

    更新日期:2007-07-12 00:00:00

  • Application of ultrasound artificial intelligence in the differential diagnosis between benign and malignant breast lesions of BI-RADS 4A.

    abstract:BACKGROUND:The classification of Breast Imaging Reporting and Data System 4A (BI-RADS 4A) lesions is mostly based on the personal experience of doctors and lacks specific and clear classification standards. The development of artificial intelligence (AI) provides a new method for BI-RADS categorisation. We analysed the...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07413-z

    authors: Niu S,Huang J,Li J,Liu X,Wang D,Zhang R,Wang Y,Shen H,Qi M,Xiao Y,Guan M,Liu H,Li D,Liu F,Wang X,Xiong Y,Gao S,Wang X,Zhu J

    更新日期:2020-10-02 00:00:00

  • Patient and tumour characteristics associated with inclusion in Cancer patient pathways in Norway in 2015-2016.

    abstract:BACKGROUND:Cancer patient pathways (CPPs) were implemented in 2015 to reduce waiting time, regional variation in waiting time, and to increase the predictability of cancer care for the patients. The aims of this study were to see if the national target of 70% of all cancer patients being included in a CPP was met, and ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-06979-y

    authors: Nilssen Y,Brustugun OT,Eriksen MT,Haug ES,Naume B,Møller B

    更新日期:2020-05-30 00:00:00

  • Lung cancer symptoms and pulse oximetry in the prognostic assessment of patients with lung cancer.

    abstract:BACKGROUND:Medical oncologists continue to use performance status as a proxy for quality of life (QOL) measures, as completion of QOL instruments is perceived as time consuming, may measure aspects of QOL not affected by cancer therapy, and interpretation may be unclear. The pulse oximeter is widely used in clinical pr...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-5-72

    authors: Martins SJ,Ho N,Cavamura SO,Harada CM,Yamamoto CA,Takagaki TY

    更新日期:2005-07-06 00:00:00

  • MicroRNA-34a is a tumor suppressor in choriocarcinoma via regulation of Delta-like1.

    abstract:BACKGROUND:Choriocarcinoma is a gestational trophoblastic tumor which causes high mortality if left untreated. MicroRNAs (miRNAs) are small non protein-coding RNAs which inhibit target gene expression. The role of miRNAs in choriocarcinoma, however, is not well understood. In this study, we examined the effect of miR-3...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-13-25

    authors: Pang RT,Leung CO,Lee CL,Lam KK,Ye TM,Chiu PC,Yeung WS

    更新日期:2013-01-18 00:00:00

  • The adaptive immune and immune checkpoint landscape of neoadjuvant treated esophageal adenocarcinoma using digital pathology quantitation.

    abstract:BACKGROUND:Limited studies examine the immune landscape in Esophageal Adenocarcinoma (EAC). We aim to identify novel associations, which may inform immunotherapy treatment stratification. METHODS:Three hundred twenty-nine EAC cases were available in Tissue Microarrays (TMA) format. A discovery cohort of 166 EAC cases ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-06987-y

    authors: Humphries MP,Craig SG,Kacprzyk R,Fisher NC,Bingham V,McQuaid S,Murray GI,McManus D,Turkington RC,James J,Salto-Tellez M

    更新日期:2020-06-01 00:00:00

  • Measuring cancer care coordination: development and validation of a questionnaire for patients.

    abstract:BACKGROUND:Improving the coordination of cancer care is a priority area for service improvement. However, quality improvement initiatives are hindered by the lack of accurate and reliable measures of this aspect of cancer care. This study was conducted to develop a questionnaire to measures patients' experience of canc...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-11-298

    authors: Young JM,Walsh J,Butow PN,Solomon MJ,Shaw J

    更新日期:2011-07-15 00:00:00

  • Expression of phosphoenolpyruvate carboxykinase linked to chemoradiation susceptibility of human colon cancer cells.

    abstract:BACKGROUND:Resistance to 5-fluorouracil (5-FU) in patients with colorectal cancer prevents effective treatment and leads to unnecessary and burdensome chemotherapy. Therefore, prediction of 5-FU resistance is imperative. METHODS:To identify the proteins linked to 5-FU resistance, two-dimensional gel electrophoresis-ba...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-160

    authors: Park JW,Kim SC,Kim WK,Hong JP,Kim KH,Yeo HY,Lee JY,Kim MS,Kim JH,Yang SY,Kim DY,Oh JH,Cho JY,Yoo BC

    更新日期:2014-03-06 00:00:00

  • Establishment of an immune-related gene pair model to predict colon adenocarcinoma prognosis.

    abstract:BACKGROUND:Colon cancer is the most common type of gastrointestinal cancer and has high morbidity and mortality. Colon adenocarcinoma (COAD) is the main pathological type of colon cancer, and much evidence has supported the correlation between the prognosis of COAD and the immune system. The current study aimed to deve...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07532-7

    authors: Luo J,Liu P,Wang L,Huang Y,Wang Y,Geng W,Chen D,Bai Y,Yang Z

    更新日期:2020-11-09 00:00:00

  • Modeling the effect of age in T1-2 breast cancer using the SEER database.

    abstract:BACKGROUND:Modeling the relationship between age and mortality for breast cancer patients may have important prognostic and therapeutic implications. METHODS:Data from 9 registries of the Surveillance, Epidemiology, and End Results Program (SEER) of the United States were used. This study employed proportional hazards...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-5-130

    authors: Tai P,Cserni G,Van De Steene J,Vlastos G,Voordeckers M,Royce M,Lee SJ,Vinh-Hung V,Storme G

    更新日期:2005-10-08 00:00:00

  • The NF-κB p65 and p50 homodimer cooperate with IRF8 to activate iNOS transcription.

    abstract:BACKGROUND:Inducible nitric oxide synthase (iNOS) metabolizes L-arginine to produce nitric oxide (NO) which was originally identified in myeloid cells as a host defense mechanism against pathogens. Recent studies, however, have revealed that iNOS is often induced in tumor cells and myeloid cells in the tumor microenvir...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-1808-6

    authors: Simon PS,Sharman SK,Lu C,Yang D,Paschall AV,Tulachan SS,Liu K

    更新日期:2015-10-23 00:00:00

  • Systematic screening as a tool for individualized rehabilitation following primary breast cancer treatment: study protocol for the ReScreen randomized controlled trial.

    abstract:BACKGROUND:It is well known that women suffer from negative consequences following breast cancer (BC) treatment and that their largely varying needs for rehabilitation are often unmet. Up to 43% of these women are at risk of developing chronic distress requiring complex interventions; however, how to early identify and...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-06815-3

    authors: Olsson Möller U,Rydén L,Malmström M

    更新日期:2020-05-29 00:00:00

  • A prospective comparison of UroVysion FISH and urine cytology in bladder cancer detection.

    abstract:BACKGROUND:UroVysion fluorescence in situ hybridization (uFISH) was reported to have superior sensitivity to urine cytology. However uFISH studies are limited by varying definitions of what is considered a positive result, absence of histopathology and small sample size. The aim of our study was to better determine the...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3227-3

    authors: Lavery HJ,Zaharieva B,McFaddin A,Heerema N,Pohar KS

    更新日期:2017-04-07 00:00:00

  • Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma.

    abstract:BACKGROUND:New biomarkers are needed for the prognosis of advanced colorectal cancer, which remains incurable by conventional treatments. O6-methylguanine DNA methyltransferase (MGMT) methylation and protein expression have been related to colorectal cancer treatment failure and tumor progression. Moreover, the presenc...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-511

    authors: Oliver JA,Ortiz R,Melguizo C,Alvarez PJ,Gómez-Millán J,Prados J

    更新日期:2014-07-11 00:00:00